| scholarly article | Q13442814 |
| P2093 | author name string | Stephen A Douglas | |
| Stephen Harrison | |||
| Zhaohui Ao | |||
| Jyoti Disa | |||
| Nambi V Aiyar | |||
| Beverly E Maleeff | |||
| Graham Duddy | |||
| Nabil A Elshourbagy | |||
| Jan L Sechler | |||
| Usman Shabon | |||
| Diane Naselsky | |||
| P2860 | cites work | Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide | Q48389752 |
| Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. | Q48418381 | ||
| Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. | Q48877778 | ||
| Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana. | Q51615880 | ||
| Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. | Q51617929 | ||
| Spasmogenic actions of frog urotensin II on the bladder and ileum of the frog, Rana catesbeiana. | Q51618294 | ||
| A Homologous Radioimmunoassay for the Measurement of Urotensin II in the Euryhaline Flounder,Platichthys flesus | Q57918050 | ||
| Human urotensin II increases coronary perfusion pressure in the isolated rat heart | Q64446803 | ||
| Functional receptors for fish neuropeptide urotensin II in major rat arteries | Q68449521 | ||
| Effects of somatostatin-25 and urotensin II on lipid and carbohydrate metabolism of coho salmon, Oncorhynchus kisutch | Q69902865 | ||
| Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line | Q70142807 | ||
| Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization | Q71489314 | ||
| Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives | Q73403316 | ||
| Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord | Q73568813 | ||
| Native urotensins influence cortisol secretion and plasma cortisol concentration in the euryhaline flounder, platichthys flesus | Q77450329 | ||
| Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 | ||
| Molecular cloning of a functional human galanin receptor | Q24306226 | ||
| Cloning and characterization of a fourth human somatostatin receptor | Q24563011 | ||
| Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord | Q24656200 | ||
| Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 | Q24674639 | ||
| A comprehensive set of sequence analysis programs for the VAX | Q26778432 | ||
| Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction | Q28137875 | ||
| Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 | Q28139196 | ||
| Human urotensin II mediates vasoconstriction via an increase in inositol phosphates | Q28140469 | ||
| Assignment of the GPR14 gene coding for the G-protein-coupled receptor 14 to human chromosome 17q25.3 by fluorescent in situ hybridization | Q28145285 | ||
| Central effects of urotensin-II following ICV administration in rats | Q28205107 | ||
| Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin | Q28242498 | ||
| Isolation of a human kappa opioid receptor cDNA from placenta | Q28246555 | ||
| A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts | Q28252109 | ||
| Molecular characterization and regulation of the human endothelin receptors | Q28266619 | ||
| Splicing of messenger RNA precursors | Q29619934 | ||
| Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). | Q30807054 | ||
| Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries | Q31833949 | ||
| Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor | Q32074989 | ||
| Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease | Q34204725 | ||
| Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression | Q34298120 | ||
| Cardiostimulant effects of urotensin-II in human heart in vitro | Q35043105 | ||
| Sequence alignment of the G-protein coupled receptor superfamily | Q35225323 | ||
| Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes | Q36404166 | ||
| Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes | Q39396237 | ||
| Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates | Q41012086 | ||
| Human AT1 receptor is a single copy gene: characterization in a stable cell line | Q41488167 | ||
| Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries | Q41859635 | ||
| Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey | Q42059806 | ||
| Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats | Q43264253 | ||
| Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. | Q43264408 | ||
| Human urotensin-II is a potent spasmogen of primate airway smooth muscle | Q43264553 | ||
| Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase | Q43633744 | ||
| Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells | Q43660489 | ||
| Inhibition of insulin release by urotensin II--a study on the perfused rat pancreas | Q43676795 | ||
| Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. | Q47928974 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 9-22 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey | |
| P478 | volume | 136 |
| Q53165879 | An investigation into the origin of the biased agonism associated with the urotensin II receptor activation. |
| Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
| Q28260943 | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes |
| Q42252347 | Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart |
| Q36609389 | Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus |
| Q42215972 | Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice |
| Q36781030 | Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation. |
| Q34260110 | Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity |
| Q43229377 | Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery. |
| Q35047377 | Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines |
| Q98629482 | Identification and signaling characterization of four urotensin II receptor subtypes in the western clawed frog, Xenopus tropicalis |
| Q78554340 | Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension |
| Q48675996 | Localization of the urotensin II receptor in the rat central nervous system |
| Q44114224 | New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide |
| Q40430686 | Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. |
| Q35128456 | Potential Clinical Implications of the Urotensin II Receptor Antagonists |
| Q39084425 | RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells. |
| Q28249171 | Renal and vascular actions of urotensin II |
| Q35025464 | Renal impairment, hypertension and plasma urotensin II. |
| Q28182651 | Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
| Q36973674 | The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification |
| Q42283626 | The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans. |
| Q28241656 | The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma |
| Q35100902 | The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems |
| Q35068002 | The urotensin system is up-regulated in the pre-hypertensive spontaneously hypertensive rat |
| Q43146165 | The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation |
| Q36760529 | Therapeutic potential of blockade of the urotensin II system in systemic hypertension |
| Q41767436 | Update on the urotensinergic system: new trends in receptor localization, activation, and drug design |
| Q54414485 | Urantide conformation and interaction with the urotensin-II receptor. |
| Q28576132 | Urotensin II and renal function in the rat |
| Q36424203 | Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice |
| Q36384743 | Urotensin II in invertebrates: from structure to function in Aplysia californica |
| Q35014906 | Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway |
| Q45732640 | Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis |
| Q40470611 | Urotensin II stimulates plasma extravasation in mice via UT receptor activation. |
| Q28250440 | Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation |
| Q38093584 | Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures |
| Q35779239 | Urotensin-II and the cardiovascular system--the importance of developing modulators |
| Q36357772 | Urotensin-II induces ear flushing in rats |
| Q39039151 | Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. |
| Q28566263 | Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators |
| Q42418210 | Urotensin-II: More Than a Mediator for Kidney |
| Q76383739 | Urotensin-II: a novel systemic hypertensive factor in the cat |
Search more.